Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.11, 2010-11, pp. : 1025-1039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abacavir plus Lamivudine: A Review of their Combined Use in the Management of HIV Infection

By Toni M. Dando Lesley J. Scott

Drugs, Vol. 65, Iss. 2, 2005-01 ,pp. : 285-302

Adis International

Access to resources Recommend Favorite

Abacavir/lamivudine fixed-dose combination tablet for the treatment of HIV-1 infection

By Taylor Clare L Wilkins Edmund GL

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 11-21

Future Medicine

Access to resources Recommend Favorite

In Mexican Mestizos the HCP5 rs2395029 SNP may be a genetic marker for screening abacavir hypersensitivity

By Sanchez-Giron Francisco Carnevale Alessandra

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 251-252

Future Medicine

Access to resources Recommend Favorite

Dolutegravir, abacavir and lamivudine as HIV therapy

By Fernandez-Montero Jose Vicente Barreiro Pablo Labarga Pablo De Mendoza Carmen Soriano Vicente

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1051-1057

Informa Healthcare

Access to resources Recommend Favorite

Genetic susceptibility to abacavir hypersensitivity determined

Inpharma, Vol. 1, Iss. 1328, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite